Logo image of MSB

MESABI TRUST (MSB) Stock Fundamental Analysis

USA - NYSE:MSB - US5906721015

30.65 USD
-0.39 (-1.26%)
Last: 10/10/2025, 8:45:16 PM
Fundamental Rating

7

Taking everything into account, MSB scores 7 out of 10 in our fundamental rating. MSB was compared to 156 industry peers in the Metals & Mining industry. MSB scores excellent points on both the profitability and health parts. This is a solid base for a good stock. MSB has a correct valuation and a medium growth rate. These ratings could make MSB a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

MSB had positive earnings in the past year.
In the past year MSB had a positive cash flow from operations.
Each year in the past 5 years MSB has been profitable.
In the past 5 years MSB always reported a positive cash flow from operatings.
MSB Yearly Net Income VS EBIT VS OCF VS FCFMSB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

1.2 Ratios

MSB's Return On Assets of 374.42% is amongst the best of the industry. MSB outperforms 100.00% of its industry peers.
The Return On Equity of MSB (407.21%) is better than 100.00% of its industry peers.
MSB has a better Return On Invested Capital (321.70%) than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MSB is significantly above the industry average of 12.18%.
The last Return On Invested Capital (321.70%) for MSB is above the 3 year average (152.08%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 374.42%
ROE 407.21%
ROIC 321.7%
ROA(3y)66.81%
ROA(5y)86.02%
ROE(3y)178.92%
ROE(5y)180.43%
ROIC(3y)152.08%
ROIC(5y)151.27%
MSB Yearly ROA, ROE, ROICMSB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500 1K 1.5K

1.3 Margins

With an excellent Profit Margin value of 96.44%, MSB belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
MSB's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 96.44%, MSB belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of MSB has remained more or less at the same level.
Industry RankSector Rank
OM 96.44%
PM (TTM) 96.44%
GM N/A
OM growth 3Y-0.05%
OM growth 5Y0.34%
PM growth 3Y-0.57%
PM growth 5Y0.13%
GM growth 3YN/A
GM growth 5YN/A
MSB Yearly Profit, Operating, Gross MarginsMSB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

9

2. Health

2.1 Basic Checks

MSB has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, MSB has about the same amount of shares outstanding.
There is no outstanding debt for MSB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MSB Yearly Shares OutstandingMSB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
MSB Yearly Total Debt VS Total AssetsMSB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

MSB has an Altman-Z score of 139.54. This indicates that MSB is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MSB (139.54) is better than 95.51% of its industry peers.
There is no outstanding debt for MSB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 139.54
ROIC/WACCN/A
WACCN/A
MSB Yearly LT Debt VS Equity VS FCFMSB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.3 Liquidity

MSB has a Current Ratio of 12.42. This indicates that MSB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MSB (12.42) is better than 91.67% of its industry peers.
MSB has a Quick Ratio of 12.42. This indicates that MSB is financially healthy and has no problem in meeting its short term obligations.
MSB has a Quick ratio of 12.42. This is amongst the best in the industry. MSB outperforms 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 12.42
Quick Ratio 12.42
MSB Yearly Current Assets VS Current LiabilitesMSB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

MSB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 423.76%, which is quite impressive.
MSB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 25.43% yearly.
The Revenue has grown by 303.09% in the past year. This is a very strong growth!
The Revenue has been growing by 25.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)423.76%
EPS 3Y10.7%
EPS 5Y25.43%
EPS Q2Q%-11.8%
Revenue 1Y (TTM)303.09%
Revenue growth 3Y11.33%
Revenue growth 5Y25.25%
Sales Q2Q%-13.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MSB Yearly Revenue VS EstimatesMSB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.34 indicates a rather cheap valuation of MSB.
100.00% of the companies in the same industry are more expensive than MSB, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of MSB to the average of the S&P500 Index (27.02), we can say MSB is valued rather cheaply.
Industry RankSector Rank
PE 4.34
Fwd PE N/A
MSB Price Earnings VS Forward Price EarningsMSB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MSB is valued cheaper than 98.72% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.27
EV/EBITDA N/A
MSB Per share dataMSB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

MSB has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

MSB has a Yearly Dividend Yield of 20.38%, which is a nice return.
Compared to an average industry Dividend Yield of 2.41, MSB pays a better dividend. On top of this MSB pays more dividend than 100.00% of the companies listed in the same industry.
MSB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 20.38%

5.2 History

The dividend of MSB decreases each year by -16.67%.
MSB has paid a dividend for at least 10 years, which is a reliable track record.
MSB has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-16.67%
Div Incr Years2
Div Non Decr Years2
MSB Yearly Dividends per shareMSB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

MSB pays out 101.83% of its income as dividend. This is not a sustainable payout ratio.
DP101.83%
EPS Next 2YN/A
EPS Next 3YN/A
MSB Yearly Income VS Free CF VS DividendMSB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
MSB Dividend Payout.MSB Dividend Payout, showing the Payout Ratio.MSB Dividend Payout.PayoutRetained Earnings

More info and screens

MESABI TRUST

NYSE:MSB (10/10/2025, 8:45:16 PM)

30.65

-0.39 (-1.26%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)09-03 2025-09-03
Earnings (Next)12-11 2025-12-11
Inst Owners45.29%
Inst Owner Change0.08%
Ins Owners0.08%
Ins Owner Change0%
Market Cap402.13M
Analysts0
Price TargetN/A
Short Float %3.4%
Short Ratio8.41
Dividend
Industry RankSector Rank
Dividend Yield 20.38%
Yearly Dividend1.35
Dividend Growth(5Y)-16.67%
DP101.83%
Div Incr Years2
Div Non Decr Years2
Ex-Date07-30 2025-07-30 (0.12)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.34
Fwd PE N/A
P/S 4.18
P/FCF 4.27
P/OCF 4.27
P/B 17.65
P/tB 17.65
EV/EBITDA N/A
EPS(TTM)7.07
EY23.07%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)7.17
FCFY23.4%
OCF(TTM)7.17
OCFY23.4%
SpS7.33
BVpS1.74
TBVpS1.74
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 374.42%
ROE 407.21%
ROCE 407.21%
ROIC 321.7%
ROICexc 4783.73%
ROICexgc 4783.73%
OM 96.44%
PM (TTM) 96.44%
GM N/A
FCFM 97.8%
ROA(3y)66.81%
ROA(5y)86.02%
ROE(3y)178.92%
ROE(5y)180.43%
ROIC(3y)152.08%
ROIC(5y)151.27%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)192.5%
ROCE(5y)191.48%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.05%
OM growth 5Y0.34%
PM growth 3Y-0.57%
PM growth 5Y0.13%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover3.88
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 101.42%
Current Ratio 12.42
Quick Ratio 12.42
Altman-Z 139.54
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)146.22%
Profit Quality(5y)123.79%
High Growth Momentum
Growth
EPS 1Y (TTM)423.76%
EPS 3Y10.7%
EPS 5Y25.43%
EPS Q2Q%-11.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)303.09%
Revenue growth 3Y11.33%
Revenue growth 5Y25.25%
Sales Q2Q%-13.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y425.33%
EBIT growth 3Y11.27%
EBIT growth 5Y25.67%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3055%
FCF growth 3Y14.34%
FCF growth 5Y22.12%
OCF growth 1Y3055%
OCF growth 3Y14.34%
OCF growth 5Y22.12%